Maxwell Biosciences is a preclinical-stage drug platform company actively developing an entirely new CLAROMER biotechnology platform that creates low-molecular-weight compounds that mimic peptides and are functionally distinct from macromolecules due to their ease of penetrating membranes.
Patient-centered, proactive medicine that maximizes the pursuit of your dreams through innovative diagnostics and technologies.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.